Keynote Presentation
Illuminating the path towards empiric safe and rapid treatment for all corneal infections
In the setting of emerging multi-drug resistant bacteria, only modest hit rate in identifying the offending organism with culture / cytology, and considering superinfection / multiple micro-organism infections there is a need to explore alternative methods to manage microbial keratitis. UVC light has been found to be an effective treatment to selectively target any prokaryotic microorganisms (bacteria / viruses / fungi / amoeba) whilst not harming the host. The evolution of PACK-CXL using UVA light in combination with riboflavin photo-activator, to just pure UVC enabling a treatment in seconds rather than minutes, without any consumables, will be presented. The data from preclinical safety and efficacy studies will be the foundation of the presentation.
Simon Dean
MBChB, MSc, FRANZCO, FBCLA
Dr Simon Dean completed medical MBChB training in Auckland New Zealand in 1997, attending medical school with the goal to be an eye surgeon. In 2007 he was awarded a fellowship of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO). He completed fellowship training in the UK in oculoplastics and ocular oncology in Glasgow, followed by cataracts and anterior segment in Birmingham, UK, and the Bedford branch of Moorfields Eye Hospital. He also holds a fellowship of the British Contact Lens Association (FBCLA) by examination. He completed his MSc in cataract and refractive surgery in 2009. Dr Dean previously held the position of Head of Department at Manukau Superclinic the second largest public eye clinic in New Zealand, for 7 years where he still works half time, and consults privately through re:vision a boutique laser and cataract surgery centre in Auckland.
With a keen interest in optics Dr Dean was the Subject Leader for the RANZCO Optics exam team for 12 years and recently has been promoted within the College to Chair of the ophthalmic sciences and COPEM. He served 13 years on the RANZCO Scientific Programme Committee. He has designed and manufactured numerous ophthalmic research and clinical devices including a CXL device, through his personal company SDZ Electronics. He is inventor, prototype manufacturer, and Chief Scientific Officer for Photon Therapeutics Ltd.
Sponsored by:
Past Keynote Speakers & Topics
Presentations have been recorded since 2011 and are available to members through the online video portal.
2022 - Dr. Gustavo Aguirre Title:” From Dogs to DNA; from the Cage to the Bedside"
2021 - Dr. Michael R. Lappin Topic: Infectious Diseases
2020 - Dr. Molly Shoichet Title:"Regenerative Medicine Strategies in the Animal Models of Blindness"
2019 - Dr. Chris Murphy, Dr. Nandini Gandhi & Dr. Mark Mannis Title: "MAKING MISTAKES: THE IMPORTANCE OF FORGIVENESS”
2018 - Dr. Douglas Rhee Title: Conquering Intraocular Pressure: New and Traditional Pharmacologic, Laser, Surgical Approaches in Humans
2017 - Dr. Carol L. Shields Title: The Colorful Spectrum of Ocular Tumors in Humans
2016 - Dr. Randy Kardon Title: Pupil Light Reflex and Its Application to Both Veterinary, Laboratory and Human Translation
2015 - Dr. John R. Heckenlively Title: Is SARDS Really Cases of Autoimmune Retinopathy? Evaluation from the Human Perspective
2014 - Dr. Robert Noecker Title: Advances in Glaucoma, Cataract and Anterior Segment Surgery
2013 - Dr. Chris McGahan Title: New Roles for Iron in Ocular Physiology
2012 - Dr. Morton Smith Title: Second most effective tool for Honing your Diagnostic skills is the CPC
2011 - Dr. Ivan Schwab Title: Evolution's Witness
2010 - Dr. Mike Robinson Title:Advances in Ocular Drug Delivery
2009 - Dr. Martin Uram Title: Endoscopic Glaucoma and Retinal Surgery
2008 - Dr. Paul Koch Title: Cataract Surgery in two-legged patients
2007 - Dr Steve Arshinoff Title: Ophthalmic Viscosurgical Devices and Techniques to use them to their full Potential
2006 - Dr. Kirk Packo Title: Intravitreal Pharmacotherapy - Using Intraocular Inections to Treat Retinal Disease
2005 - Dr. Robert Anderson Title: Where are Omega-3 Fatty Acids and why are they so Important to the Retina?
2004 - Dr. Gustavo Aguirre Title: Gene Therapy for Retinal Disease in Dogs